Table 4 Detection rate for CNVs and nucleotide variants among the 253 ASD subjects stratified by clinical subgroups.

From: Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use

 

ASD+ID n = 68

ASD n = 95

Asperger n = 90

Total n = 253

CNVs

7

5

6

18–7.1% [4.3–11%]

Nucleotide variants

14

8

10

32–12.6% [8.8–17.4%]

Total

21–30.1% [20.2–43.2%]

13–13.7% [7.5–22.3%]

16–17.7% [10.5–27.3%]

50–19.7% [15–25.2%]

Back to article page